New Nordic (Sweden) Performance
| NNH Stock | SEK 14.90 0.20 1.36% |
The company secures a Beta (Market Risk) of -0.2, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning New Nordic are expected to decrease at a much lower rate. During the bear market, New Nordic is likely to outperform the market. At this point, New Nordic Healthbrands has a negative expected return of -0.12%. Please make sure to verify New Nordic's kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if New Nordic Healthbrands performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days New Nordic Healthbrands has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors. ...more
| Begin Period Cash Flow | 10.4 M | |
| Total Cashflows From Investing Activities | -3 M |
New |
New Nordic Relative Risk vs. Return Landscape
If you would invest 1,650 in New Nordic Healthbrands on September 1, 2024 and sell it today you would lose (160.00) from holding New Nordic Healthbrands or give up 9.7% of portfolio value over 90 days. New Nordic Healthbrands is producing return of less than zero assuming 2.8284% volatility of returns over the 90 days investment horizon. Simply put, 25% of all stocks have less volatile historical return distribution than New Nordic, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
New Nordic Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for New Nordic's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as New Nordic Healthbrands, and traders can use it to determine the average amount a New Nordic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0412
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NNH |
Estimated Market Risk
| 2.83 actual daily | 25 75% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average New Nordic is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of New Nordic by adding New Nordic to a well-diversified portfolio.
New Nordic Fundamentals Growth
New Stock prices reflect investors' perceptions of the future prospects and financial health of New Nordic, and New Nordic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on New Stock performance.
| Return On Equity | -0.0316 | |||
| Return On Asset | -0.0058 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | (0) % | |||
| Current Valuation | 221.83 M | |||
| Shares Outstanding | 6.2 M | |||
| Price To Earning | 17.52 X | |||
| Price To Book | 1.56 X | |||
| Price To Sales | 0.36 X | |||
| Revenue | 514.85 M | |||
| EBITDA | 29.48 M | |||
| Cash And Equivalents | 11.88 M | |||
| Cash Per Share | 3.16 X | |||
| Total Debt | 1.24 M | |||
| Debt To Equity | 0.80 % | |||
| Book Value Per Share | 18.74 X | |||
| Cash Flow From Operations | (7.87 M) | |||
| Earnings Per Share | 1.91 X | |||
| Total Asset | 238.35 M | |||
| Retained Earnings | 32 M | |||
| Current Asset | 130 M | |||
| Current Liabilities | 98 M | |||
About New Nordic Performance
Assessing New Nordic's fundamental ratios provides investors with valuable insights into New Nordic's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the New Nordic is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
New Nordic Healthbrands AB develops and markets branded food supplements, natural remedies, and related personal care products. New Nordic Healthbrands AB was founded in 1990 and is based in Malm, Sweden. New Nordic operates under Healthcare Products classification in Sweden and is traded on Stockholm Stock Exchange. It employs 49 people.Things to note about New Nordic Healthbrands performance evaluation
Checking the ongoing alerts about New Nordic for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for New Nordic Healthbrands help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| New Nordic generated a negative expected return over the last 90 days | |
| New Nordic Healthbrands has accumulated about 11.88 M in cash with (7.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.16. | |
| Roughly 48.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing New Nordic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether New Nordic's stock is overvalued or undervalued compared to its peers.
- Examining New Nordic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating New Nordic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of New Nordic's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of New Nordic's stock. These opinions can provide insight into New Nordic's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for New Stock Analysis
When running New Nordic's price analysis, check to measure New Nordic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy New Nordic is operating at the current time. Most of New Nordic's value examination focuses on studying past and present price action to predict the probability of New Nordic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move New Nordic's price. Additionally, you may evaluate how the addition of New Nordic to your portfolios can decrease your overall portfolio volatility.